Cooley
For more than 40 years, Cooley’s top-ranked team has represented innovators and investors across cutting-edge fields in the healthcare and life sciences industry. Cooley leverages its global, full-service platform to advise on financing, corporate partnering & licensing, M&A and public offerings, as well as litigation, regulatory and intellectual property needs. No other legal team boasts Cooley’s level of experience guiding companies throughout every stage of growth.
Learn More
Resources
- Following Recent Policy Statement, FTC ‘Disputes’ 100+ Patent Listings in FDA Orange Book (Nov 2023)
- Webinar: Privacy Talks Series: Regulating Dark Patterns and Design (Oct 2023)
- FTC Issues Antitrust Warning Against ‘Improper’ Orange Book Patent Listings (Oct 2023)
- Webinar: Privacy Talks Series: Meeting the CCPA’s Training Requirements (Sept 2023)
- European Commission Publishes Proposals to Revise Current EU Pharmaceutical Legislative Framework (Apr 2023)
- FTC Revises Health Products Compliance Guidance (Mar 2023)
- FDORA Changes to the FDA Accelerated Approval Program (Jan 2023)
- California’s Broad Pay Transparency Law Takes Effect Next Year (Oct 2022)